apomorphine has been researched along with bromodeoxyuridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chen, K; Connor, B; Hughes, SM; Vazey, EM | 1 |
| Domanska-Janik, K; Gielecki, J; Gornicka-Pawlak, E; Janowski, M; Kozlowska, H; Lukomska, B | 1 |
| Chen, Y; Ding, Z; Jiang, Y; Ren, H; Su, Y; Wang, J; Wu, J; Yu, W | 1 |
4 other study(ies) available for apomorphine and bromodeoxyuridine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
Topics: Analysis of Variance; Animals; Apomorphine; Brain Tissue Transplantation; Bromodeoxyuridine; Cell Count; Cell Differentiation; Disease Models, Animal; Dopamine Agonists; Huntington Disease; Immunohistochemistry; Male; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Quinolinic Acid; Rats; Rats, Wistar; Stem Cell Transplantation; Time Factors; Transcription Factors; Tyrosine 3-Monooxygenase | 2006 |
Structural and functional characteristic of a model for deep-seated lacunar infarct in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Infarction; Bromodeoxyuridine; Cell Proliferation; Discrimination Learning; Disease Models, Animal; Male; Motor Activity; Nerve Tissue Proteins; Neuropsychological Tests; Ouabain; Psychomotor Performance; Rats; Rats, Wistar; Statistics, Nonparametric; Time Factors | 2008 |
Intrastriatal transplantation of GDNF-engineered BMSCs and its neuroprotection in lactacystin-induced Parkinsonian rat model.
Topics: Acetylcysteine; Animals; Antimetabolites; Apomorphine; Behavior, Animal; Blotting, Western; Bone Marrow Transplantation; Bromodeoxyuridine; Cysteine Proteinase Inhibitors; Dopamine; Dopamine Agonists; Glial Cell Line-Derived Neurotrophic Factor; Immunohistochemistry; Neostriatum; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Tissue Engineering; Tyrosine 3-Monooxygenase | 2010 |